Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

By Piedmont Heart Institute FEATURING Jaime Burkle

1,733 views

January 25, 2022

1 Comment

Chest Pain in Women: CT's role in making an accurate diagnosis

Feat. L. Shaw, M. Gulati

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Primer on Diabetes Management

Feat. S. Inzucchi

26:11

13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff

12:04

Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

11:37

ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich

28:13

National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason

11:25

ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster

24:25

Children’s Hospital of Philadephia - General Pediatrics

Thyroid Pediatric Exam

Feat. A. Bauer

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo

15:06

Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo

12:26

Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

27:14

MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz

15:33

Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

12:30

Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg

13:07

Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

26:32

Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen

09:52

AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz

20:24

Diana Isaacs

Login

Login

Join VuMedi

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Related Content